trending Market Intelligence /marketintelligence/en/news-insights/trending/jPxq14dxQ1a0JbWYWH6taA2 content esgSubNav
In This List

Aeglea Biotherapeutics starts common stock offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Aeglea Biotherapeutics starts common stock offering

Aeglea Biotherapeutics Inc. started an underwritten public offering of common shares to raise funds for research and development of its product candidates.

JonesTrading Institutional Services LLC is the sole book-runner for the offering, which is yet to be priced. The biotechnology company plans to grant the underwriter a 30-day option to buy up to an additional 15% of the shares offered.